New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 16, 2014
10:24 EDTLCI, HCA, LYG, XON, FOXA, FTNT, ASML, BKE, TSEM, AMSCHigh option volume stocks:
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 >>
November 20, 2015
13:10 EDTASMLASML added to short-term sell list at Deutsche Bank
Subscribe for More Information
11:45 EDTFOXABox Office Battle: 'Hunger Games' finale expected to top box office
Lions Gate's (LGF) "The Hunger Games: Mockingjay - Part 2," the final movie based on the dystopian young adult novels, is opening this weekend at 4,175 theaters and is expecting a domestic gross in the range of $120M-$127M. Piper Jaffray analyst James Marsh said in a note to investors on November 18 that he expects the film to open domestically in the $130M range, above where it is tracking, due to limited competition and the addition of IMAX (IMAX) screens. Piper maintained its Overweight rating and $45 price target on Lions Gate shares at that time. "The Hunger Games" main competition is "Spectre" and "The Peanuts Movie," both of which are in their third weekend of release. Sony's (SNE) "Spectre," starring Daniel Craig as James Bond, is expected to earn another $15.2M-$16.8M. Fox's (FOX, FOXA) G-rated family film, starring a 3D-animated Charlie Brown, is predicted to earn an additional $12.5M-$13.2M. In other box office news, the Wall Street Journal reported that Disney's (DIS) "Star Wars: The Force Awakens," which hits theaters on December 18, has had record-breaking pre-sales. Fandango said the film has already sold more tickets than any other movie before its release, which is still four weeks away, and IMAX said the movie has "doubled" its prior pre-sales record of about $9M. Other publicly traded companies involved in filmmaking include Comcast (CMCSA, CMCSK), Time Warner (TWX), and Viacom (VIA, VIAB).
10:49 EDTBKEAbercrombie & Fitch soars after reporting upbeat Q3 earnings
Abercrombie & Fitch (ANF) shares jumped in morning trading after the company reported better than expected quarterly earnings. WHAT'S NEW: Before the market open, Abercrombie & Fitch reported third quarter adjusted earnings per share of 48c on revenue of $878.6M. The consensus was for EPS of 22c on revenue of $864.65M. The company said that the adjusted EPS figure included year-over-year adverse effects from changes in foreign currency exchange rates amounting to roughly 13c. Commenting on the earnings, executive chairman Arthur Martinez said that the company's results "exceeded" expectations and "provide the strongest validation yet" that the retailer's initiatives are working. WHAT'S NOTABLE: On its Q3 earnings conference call, Abercrombie said that it is eyeing expansion outside of the U.S., aiming to roll out multiple new capabilities in the U.K. The company added that it saw growth in China in the past quarter and plans to add mobile enhancements in China in 2016. STREET RESEARCH: A day before Abercrombie's Q3 earnings release, Susquehanna analyst Thomas Filandro said that the retailer was "well positioned" for the holiday season, though weather and international unrest may lead to a higher degree of near-term uncertainty. Filandro said that his firm sees improved holiday performance as Abercrombie shifts focus on an improved in-store experience, growing U.S. outlets, closing underperforming stores, and evolving its merchandise assortment. The analyst reiterated a Positive rating and a $26 price target on the company's stock. After the retailer reported earnings, KeyBanc analyst Edward Yruma maintained an Overweight rating on Abercrombie's shares, saying that the company's better than expected quarter was "particularly impressive" in light of the recent weakness in the retail sector. Yruma said that the company's new brand initiatives are taking hold and that greater expense control and reduced promotional activity are improving the well-being of the business. PRICE ACTION: In morning trading, Abercrombie & Fitch rallied over 18% to $23.00. OTHERS TO WATCH: American Eagle Outfitters (AEO) was up just under 3%, Aeropostale (ARO) gained 0.75%, Tilly's (TLYS) rallied 3.4%, Urban Outfitters (URBN) jumped more than 4%, Buckle (BKE) was up just under 1%, and Express (EXPR) fell fractionally in morning trading.
November 19, 2015
16:23 EDTHCAOn The Fly: Top stock stories for Thursday
The major averages spent most of the day in a narrow range bouncing around the flatline, seeming content to consolidate the gains from their rally of the last three days. The market internals confirmed the lackluster session, as the number of advancing stocks were generally in line with declining stocks. Oil prices remained under pressure for much of the session, but closed the day little changed, similar to equities. ECONOMIC EVENTS: In the U.S., jobless claims are still near four-decade lows, with 271,000 first-time claims filed in the week ended November 14. The Philly Fed index rose 6.4 points to 1.9 in November, better than the forecast for a -0.5 reading. In Europe, minutes from the most recent European Central Bank policy meeting showed that some participants called for more stimulus amid deflation risks, weak oil prices and a sluggish recovery in the regions' economy. In Asia, the Bank of Japan maintained its current pace of monetary stimulus, as expected. COMPANY NEWS: The biggest U.S. health insurer said this morning that it is considering pulling out of Obamacare due to losses it has suffered from its participation in the program and cut its profit outlook for this fiscal year, sending its shares and those of its industry peers lower. UnitedHealth (UNH) fell $6.62, or 5.65%, to $110.63 after trimming its fiscal 2015 earnings outlook, citing the Affordable Care Act, and stating that it is "evaluating the viability of the insurance exchange product segment." Meanwhile, Aetna (AET) declined 6.5%, Humana (HUM) dropped 4%, Anthem (ANTM) declined almost 7% and Cigna (CI) slid over 5% following their rival's announcement. Hospital stocks fell as well, with HCA Holdings (HCA), LifePoint (LPNT), Community Health (CYH) and Tenet (THC) all ending the day lower by 6% or more... Last night, Bloomberg reported that Pfizer (PFE) is nearing an agreement to acquire Allergan (AGN) for $370 to $380 per share, citing people familiar with the matter. CNBC's David Faber then reported that deal talks are in the "final innings" and centered on an all stock transaction whereby Pfizer would offer 11-plus shares per Allergan share. Then, people close to the talks told Financial Times that the U.S. drugmaker is preparing to offer more than $380 per share for Allergan. Amid all these reports, Treasury Secretary Jacob Lew said that his department will release "targeted guidance" later this week meant to "deter and reduce further the economic benefits of corporate inversions" like the one being contemplated by the drugmakers. Government intervention concerns appeared to trump the pricing reports, as Allergan closed the day 2.8% lower at $301.73, while Pfizer fell 3% to $32.29 per share... Intel (INTC) rose 3.4% to $34.30 after the chipmaking giant hosted its annual investor meeting, at which it announced an increase to its dividend and guided for "mid-single digits" percentage revenue growth in fiscal 2016. MAJOR MOVERS: Among the notable gainers was Keurig Green Mountain (GMCR), which surged $7.38, or 18.22%, to $47.88 after it reported better than expected quarterly earnings and guided for fiscal 2016. Also higher was Square (SQ), which rose $4.07, or 45%, to close its first day as a publicly-traded company at $13.07 after pricing its initial public offering at $9 per share. Twitter (TWTR), which, like Square, claims Jack Dorsey as its CEO, gained 1.6% to $26.32 following Square's public debut. Another high-profile tech company also gained in its first day of public trading, as Match Group (MTCH), the owner of dating app Tinder and other online dating services, climbed 22.8% to $14.74 after pricing its IPO at $12 per share. Among the noteworthy losers was Kirkland's (KIRK), which fell nearly 33% to $13.60 after the company reported downbeat quarterly earnings and provided lower than expected guidance. Also lower were shares of AMAG Pharmaceuticals (AMAG), which lost 9.84% to $26.20 after it received a complete response letter from the FDA for its proposed treatment to reduce the risk of preterm birth in at-risk patients. INDEXES: The Dow fell 4.41, or 0.02%, to 17,732.75, the Nasdaq slid 1.56, or 0.03%, to 5,073.64, and the S&P 500 declined 2.34, or 0.11%, to 2,081.24.
10:02 EDTFOXA21st Century Fox establishes partnership with Tony Sella
Subscribe for More Information
09:29 EDTXONIntrexon's AquaAdvantage salmon approved by FDA
Subscribe for More Information
07:15 EDTFTNTPalo Alto Fortinet seen as potential Cisco takeover targets, says Oppenheimer
Subscribe for More Information
07:01 EDTBKEThe Buckle reports Q3 EPS 74c, consensus 78c
Reports Q3 revenue $280.2M, consensus $281.43M. Comparable store net sales for the 13-week period ended October 31, 2015 decreased 5.2% from comparable store net sales for the prior year 13-week period ended November 1, 2014. Online sales increased 13.6% to $25.9M for the 13-week period ended October 31, 2015, compared to net sales of $22.8M for the 13-week period ended November 1, 2014.
November 18, 2015
14:38 EDTBKENotable companies reporting before tomorrow's open
Subscribe for More Information
10:55 EDTBKEThe Buckle volatility elevated into Q3 and outlook
Subscribe for More Information
09:23 EDTTSEMTowerJazz to acquire Maxim Integrated facility in San Antonio
TowerJazz (TSEM) has signed an agreement with Maxim Integrated (MXIM) to purchase Maxim's 8-inch fabrication facility in San Antonio, Texas. The proposed purchase will expand TowerJazz's current worldwide manufacturing capacity, cost-effectively increasing production by approximately 28K wafers per month. TowerJazz and Maxim expect to close the transaction in January 2016. As part of the transaction, the companies have also signed a long-term supply agreement for TowerJazz to manufacture products for Maxim in the San Antonio facility. The transaction is to be paid with TSEM ordinary shares with a total value of approximately $40M. All of the site's nearly 500 employees will be retained.
08:16 EDTXONOragenics announces completion of pre-IND meeting for OG253
Subscribe for More Information
07:59 EDTASMLUBS to hold a conference
Subscribe for More Information
06:16 EDTFOXAComcast dumps YES Network, WSJ reports
Subscribe for More Information
November 17, 2015
11:37 EDTTSEMTowerJazz to host analyst and investor day
Subscribe for More Information
11:22 EDTTSEMTowerJazz management to meet with Drexel Hamilton
Subscribe for More Information
11:21 EDTTSEMTowerJazz to host 2015 Supplier Day Meeting
Supplier Day Meeting to be held in Newport Beach, CA on November 17 at 4:30 pm.
November 16, 2015
16:43 EDTFOXAGreenlight Capital added Apple, sold some SunEdison
Greenlight Capital gave a quarterly update on its stakes in a filing this afternoon. NEW STAKES: CNX Coal Resources (CNXC), Garmin (GRMN), Terraform Global (GLBL), and Liberty Global (LILA). INCREASED STAKES: Apple (AAPL), Michael Kors (KORS), Dillard's (DDS), UIL Holdings (UIL), and Twenty-First Century Fox (FOXA). DECREASED STAKES: SunEdison (SUNE), Micron (MU), Voya (VOYA), Applied Materials (AMAT), and SunEdison Semiconductor (SEMI). LIQUIDATED STAKES: Citizens Financial (CFG), Lam Research (LRCX), Spirit AeroSystems (SPR), Hertz (HTZ), and Macy's (M).
09:59 EDTFOXAOmega bought Valeant in Q3, sold some SuneEdison
Leon Cooperman's Omega Advisors gave a quarterly update on its stakes in a filing this morning, disclosing its positions as of September 30. NEW STAKES: Pfizer (PFE), Valeant (VRX) Walgreens Boots Alliance (WBA), TerraForm Global (GLBL), Cigna (CI). INCREASED STAKES: Google Class A (GOOGL), Facebook (FB), Delta Air Lines (DAL). DECREASED STAKES: SunEdison (SUNE), Shire (SHPG), Citi (C), KAR Auction (KAR), LyondellBasell (LYB). LIQUIDATED STAKES: McKesson (MCK), 21st Century Fox (FOXA), General Motors (GM), QEP Resources (QEP), eBay (EBAY).
November 15, 2015
17:09 EDTFOXA'Spectre' stays uncatchable while Christmas-themed 'Coopers' outperforms
"Spectre" and "The Peanuts" remained in first and second place, respectively, at the domestic box office while Christmas comedy "Love The Coopers" topped expectations heading into the holiday period. WEEKEND LEADER: Sony's (SNE) "Spectre" grossed $35.4M in the U.S. for the weekend of November 15, falling roughly 50% from its $73M domestic open. Globally speaking, the latest James Bond film has pulled in $543.8M in just its second week at the box office. BOX OFFICE RUNNERS-UP: Fox's (FOX, FOXA) "The Peanuts Movie" earned $24.2M, as Charlie Brown and friends fell somewhat short of analyst expectations for $28.7M. Meanwhile, Lionsgate's (LGF) Christmas-themed comedy "Love The Coopers" debuted at $8.4M, beating estimates of $5.2M-$8M despite harsh reviews. Rounding out the weekend's Top 5 were Fox's "The Martian" with $6.7M and newcomer "The 33" at $5.8M. Analyst expectations ranged $5.5M-$10M for the disaster survival drama from Time Warner's (TWX) Warner Bros.
1 | 2 >>

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the disclaimer & terms of use